Literature DB >> 8227861

Isolation and characterization of a major allergenic component (gp55) of Aspergillus fumigatus.

R Teshima1, H Ikebuchi, J Sawada, S Miyachi, S Kitani, M Iwama, M Irie, M Ichinoe, T Terao.   

Abstract

IgE class antibodies specific for antigens in a water-soluble extract of Aspergillus fumigatus (strain NHL-5759) were analyzed by immunoblotting with sera from patients with allergic bronchopulmonary aspergillosis. All the sera tested were reactive with a major 50 to 60 kd protein in the extract. This allergen, designated gp55, was purified by gel filtration and preparative sodium dodecyl sulfate-polyacrylamide gel electrophoresis. The antigen was found to be present in the water-soluble extract in the form of a complex composed of approximately eight molecules of gp55. The carbohydrate and phosphate content of the purified antigen were 23.1% and 0.46%, respectively. The molar ratio of mannose to galactose residues was 2.76:1, and the protein was glycosylated predominantly with N-linked oligosaccharides. The serologic activity of the gp55 antigen was abolished by treatment with nonspecific protease (Pronase) but not by treatment with sodium metaperiodate or endoglycosidases. Thus the major antigenic site of the glycoprotein is located within its peptide moiety. The antigen itself displayed no chymotryptic or tryptic activity. The amino acid sequence of the 20 N-terminal residues of the antigen (ATPHEPVFFSWDAGAVTSFP) is different from that of any other protein previously reported.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8227861     DOI: 10.1016/0091-6749(93)90013-6

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  10 in total

1.  Identification of 45 kD antigen in immune complexes of patients of allergic bronchopulmonary aspergillosis.

Authors:  T Madan; B Banerjee; P K Bhatnagar; A Shah; P U Sarma
Journal:  Mol Cell Biochem       Date:  1997-01       Impact factor: 3.396

Review 2.  Allergic and invasive aspergillosis.

Authors:  J P Burnie
Journal:  J R Soc Med       Date:  1995       Impact factor: 5.344

3.  Allergen nomenclature. IUIS/WHO Allergen Nomenclature Subcommittee.

Authors: 
Journal:  Bull World Health Organ       Date:  1994       Impact factor: 9.408

Review 4.  Aspergillus fumigatus and aspergillosis.

Authors:  J P Latgé
Journal:  Clin Microbiol Rev       Date:  1999-04       Impact factor: 26.132

5.  Identification and expression of an allergen Asp f 13 from Aspergillus fumigatus and epitope mapping using human IgE antibodies and rabbit polyclonal antibodies.

Authors:  L P Chow; S L Liu; C J Yu; H K Liao; J J Tsai; T K Tang
Journal:  Biochem J       Date:  2000-03-01       Impact factor: 3.857

6.  Characterization of the Aspergillus nidulans aspnd1 gene demonstrates that the ASPND1 antigen, which it encodes, and several Aspergillus fumigatus immunodominant antigens belong to the same family.

Authors:  J A Calera; M C Ovejero; R López-Medrano; M Segurado; P Puente; F Leal
Journal:  Infect Immun       Date:  1997-04       Impact factor: 3.441

7.  Lung surfactant proteins A and D can inhibit specific IgE binding to the allergens of Aspergillus fumigatus and block allergen-induced histamine release from human basophils.

Authors:  T Madan; U Kishore; A Shah; P Eggleton; P Strong; J Y Wang; S S Aggrawal; P U Sarma; K B Reid
Journal:  Clin Exp Immunol       Date:  1997-11       Impact factor: 4.330

8.  Expression and characterization of Asp fI, an immunodominant allergen/antigen of A. fumigatus in insect cell.

Authors:  Priyanka Priyadarsiny; Prabodha K Swain; P Usha Sarma
Journal:  Mol Cell Biochem       Date:  2003-10       Impact factor: 3.396

9.  Immunological characterization of Asp f 2, a major allergen from Aspergillus fumigatus associated with allergic bronchopulmonary aspergillosis.

Authors:  B Banerjee; P A Greenberger; J N Fink; V P Kurup
Journal:  Infect Immun       Date:  1998-11       Impact factor: 3.441

Review 10.  Fungal allergens.

Authors:  W E Horner; A Helbling; J E Salvaggio; S B Lehrer
Journal:  Clin Microbiol Rev       Date:  1995-04       Impact factor: 26.132

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.